JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
about
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinomaPatient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition.Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC.Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.Induction of PD-L1 expression by epidermal growth factor receptor-mediated signaling in esophageal squamous cell carcinoma.The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma.Inflammation related genes are upregulated in surgical margins of advanced stage oral squamous cell carcinoma.Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.Targeting the IL-6/JAK/STAT3 signalling axis in cancer.Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
P2860
Q28074691-4A85BF4D-26E0-4409-B564-E5122A1D54D5Q33457995-61D9E1C4-9087-4A38-BFE7-0A3DF59CD97AQ35803714-71A85AF5-0366-446F-86BC-B1322BDCC0E2Q36642668-21E8092E-5A82-49E7-8033-E121D3F57443Q36685448-1D0586BD-4490-46FC-A78D-1349B4EA3321Q36693061-8BE9118C-158C-4DDB-833C-FF2737A6DD13Q37631581-619E1661-FAB2-49BA-ABBB-F3160CE6C0ADQ37650062-22CC2DA6-1E49-4DFD-804E-546799028A3BQ38687571-687AE3B0-BFA7-4607-B0CA-2D2B164A00C5Q38815335-232ADBD0-888F-439A-A109-A8DFCE0CF01BQ47139075-836A4639-FCF7-46EE-82F3-404F29C8B687Q47253710-228745BF-F249-4E2A-A0C7-1D3AA6E081EDQ50191433-B295138A-50D4-4992-9C3E-DDAC3A20B2FCQ52607328-F9257D9A-68FE-4DFD-90D8-4089653D88D5
P2860
JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
JAK kinase inhibition abrogate ...... s cell carcinoma tumor growth.
@ast
JAK kinase inhibition abrogate ...... s cell carcinoma tumor growth.
@en
type
label
JAK kinase inhibition abrogate ...... s cell carcinoma tumor growth.
@ast
JAK kinase inhibition abrogate ...... s cell carcinoma tumor growth.
@en
prefLabel
JAK kinase inhibition abrogate ...... s cell carcinoma tumor growth.
@ast
JAK kinase inhibition abrogate ...... s cell carcinoma tumor growth.
@en
P2093
P2860
P50
P1433
P1476
JAK kinase inhibition abrogate ...... us cell carcinoma tumor growth
@en
P2093
John Black
Kara A DeGrave
Maria L Freilino
Netanya I Pollock
Sonali Joyce
P2860
P304
P356
10.1016/J.NEO.2015.01.003
P577
2015-03-01T00:00:00Z